Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

被引:847
作者
Yamamoto, A [1 ]
Lucas, JJ [1 ]
Hen, R [1 ]
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
D O I
10.1016/S0092-8674(00)80623-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative disorders like Huntington's disease (HD) are characterized by progressive and putative irreversible clinical and neuropathological symptoms, including neuronal protein aggregates. Conditional transgenic models of neurodegenerative diseases therefore could be a powerful means to explore the relationship between mutant protein expression and progression of the disease. We have created a conditional model of HD by using the tet-regulatable system. Mice expressing a mutated huntingtin fragment demonstrate neuronal inclusions, characteristic neuropathology, and progressive motor dysfunction. Blockade of expression in symptomatic mice leads to a disappearance of inclusions and an amelioration of the behavioral phenotype. We thus demonstrate that a continuous influx of the mutant protein is required to maintain inclusions and symptoms, raising the possibility that HD may be reversible.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 54 条
[21]   Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity [J].
Hansson, O ;
Petersén, Å ;
Leist, M ;
Nicotera, P ;
Castilho, RF ;
Brundin, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8727-8732
[22]   EARLY LOSS OF NEOSTRIATAL STRIOSOME NEURONS IN HUNTINGTONS-DISEASE [J].
HEDREEN, JC ;
FOLSTEIN, SE .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (01) :105-120
[23]   A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration [J].
Hodgson, JG ;
Agopyan, N ;
Gutekunst, CA ;
Leavitt, BR ;
LePiane, F ;
Singaraja, R ;
Smith, DJ ;
Bissada, N ;
McCutcheon, K ;
Nasir, J ;
Jamot, L ;
Li, XJ ;
Stevens, ME ;
Rosemond, E ;
Roder, JC ;
Phillips, AG ;
Rubin, EM ;
Hersch, SM ;
Hayden, MR .
NEURON, 1999, 23 (01) :181-192
[24]   Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells [J].
Kazantsev, A ;
Preisinger, E ;
Dranovsky, A ;
Goldgaber, D ;
Housman, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11404-11409
[25]   Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice [J].
Kistner, A ;
Gossen, M ;
Zimmermann, F ;
Jerecic, J ;
Ullmer, C ;
Lubbert, H ;
Bujard, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10933-10938
[26]   Ataxin-1 nuclear localization and aggregation:: Role in polyglutamine-induced disease in SCA1 transgenic mice [J].
Klement, IA ;
Skinner, PJ ;
Kaytor, MD ;
Yi, H ;
Hersch, SM ;
Clark, HB ;
Zoghbi, HY ;
Orr, HT .
CELL, 1998, 95 (01) :41-53
[27]   The CAG/polyglutamine tract diseases: Gene products and molecular pathogenesis [J].
Koshy, BT ;
Zoghbi, HY .
BRAIN PATHOLOGY, 1997, 7 (03) :927-942
[28]   Structural neurology: Are seeds at the root of neuronal degeneration? [J].
Lansbury, PT .
NEURON, 1997, 19 (06) :1151-1154
[29]  
Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO
[30]  
2-F